Evidence map›Paper›PMID 29301485›Full record

ArticleBMC bioinformatics2018

Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform.

Aditya Deshpande, Wenhua Lang, Tina McDowell, Smruthy Sivakumar, Jiexin Zhang, Jing Wang, F Anthony San Lucas, Jerry Fowler, Humam Kadara, Paul Scheet

Abstract read
In one paragraph

Article in BMC bioinformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer.American journal of respiratory and critical care medicine · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aditya DeshpandeDepartments of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wenhua LangTranslational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tina McDowellTranslational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Smruthy SivakumarDepartments of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jiexin ZhangBioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jing WangBioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
F Anthony San LucasDepartments of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jerry FowlerDepartments of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Humam KadaraDepartment of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, Lebanon. hk94@aub.edu.lb.
Paul ScheetDepartments of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. pscheet@alum.wustl.edu.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Statistical Methods for Population Genomics and "Next-gen" Sequencing DataR01HG005859 · NHGRI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SCHEET, PAUL A · 2011 to 2015
$1.9M
(PQ1) Progression of the airway field of injury to Kras mutant lung cancerR01CA205608 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KADARA, HUMAM, SCHEET, PAUL A · 2016 to 2019
$1.4M
Clinical Utility of Genetic Markers Associated with Early Onset Prostate CancerR03CA150079 · NCI · FOX CHASE CANCER CENTER · PI GIRI, VEDA N. · 2010 to 2011
$172k
Cancer Prevention and Research Institute of Texas (US) RP150079NCI NIH HHS P30 CA016672NCI NIH HHS P30CA016677NCI NIH HHS R01 CA205608NCI NIH HHS R01HG005859NHGRI NIH HHS R01 HG005859
6 · The paper itself

Abstract

background'Next-generation' (NGS) sequencing has wide application in medical genetics, including the detection of somatic variation in cancer. The Ion Torrent-based (IONT) platform is among NGS technologies employed in clinical, research and diagnostic settings. However, identifying mutations from IONT deep sequencing with high confidence has remained a challenge. We compared various computational variant-calling methods to derive a variant identification pipeline that may improve the molecular diagnostic and research utility of IONT.

resultsUsing IONT, we surveyed variants from the 409-gene Comprehensive Cancer Panel in whole-section tumors, intra-tumoral biopsies and matched normal samples obtained from frozen tissues and blood from four early-stage non-small cell lung cancer (NSCLC) patients. We used MuTect, Varscan2, IONT's proprietary Ion Reporter, and a simple subtraction we called "Poor Man's Caller." Together these produced calls at 637 loci across all samples. Visual validation of 434 called variants was performed, and performance of the methods assessed individually and in combination. Of the subset of inspected putative variant calls (n=223) in genomic regions that were not intronic or intergenic, 68 variants (30%) were deemed valid after visual inspection. Among the individual methods, the Ion Reporter method offered perhaps the most reasonable tradeoffs. Ion Reporter captured 83% of all discovered variants; 50% of its variants were visually validated. Aggregating results from multiple packages offered varied improvements in performance.

conclusionsOverall, Ion Reporter offered the most attractive performance among the individual callers. This study suggests combined strategies to maximize sensitivity and positive predictive value in variant calling using IONT deep sequencing.

Indexed as

Carcinoma, Non-Small-Cell LungHigh-Throughput Nucleotide SequencingHumansLung NeoplasmsMutationSequence Analysis, DNASoftwareIon ReporterIon torrentMuTectNext-generation sequencingVariant calling strategiesVarscan2

Identifiers

PMID29301485
PMCPMC5753459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.